Together we will beat cancer

Blank Avatar

Áine studied genetics at University College Cork, Ireland before making the move to London in 2010 and completing a PhD in cancer biology at Barts Cancer Institute. She joined the science communications team at Cancer Research UK in 2014 where she works to communicate the charity’s research to the public.

News digest – apricot kernels, CRISPR, waiting time target missed (again) and… is tap water bad?

Apricot kernels, CRISPR, waiting time target missed and is tap water bad? Here’s this week’s cancer news.

Read More

How imaging could help personalise breast cancer treatment

Advanced imaging technology is helping our scientists understand how key molecules fuel the growth of breast cancer cells.

Read More

Making blood vessels ‘leaky’ could help treat children’s brain tumours

A new study published today by a group of scientists could explain why there are such differences in survival between medulloblastoma patients.

Read More

‘Unprecedented’ breast cancer trial results explained

UK researchers running a clinical trial have presented some exciting preliminary results at a European breast cancer conference

Read More

How does alcohol cause cancer?

We explore the science behind how alcohol affects and damages our cells, and how this can cause the cells in our bodies to develop into cancer.

Read More

Grand Challenge seven: kill cancer cells using new ‘smart drugs’

We explore our seventh Grand Challenge, attempting to pull off the ultimate cell heist and use new ‘smart drugs’ to selectively kill cancer cells.

Read More

The biggest cancer science stories of 2015

We’ve enlisted the help of one of our researchers to pick out the biggest cancer research stories of 2015.

Read More

‘Thank you for teaching me new stuff’ – Oscar’s story: the sequel

Future scientist Oscar Sawyers came to our head office earlier this year. Find out how he got on and about his incredible fundraising achievement.

Read More

Our milestones: How anastrozole became a number one hit

This entry is part 25 of 30 in the series Our milestones

We look at one of Cancer Research UK’s key trials, proving the drug anastrozole should be the gold standard for treating breast cancer in postmenopausal women.

Read More